Moisturisers in the treatment of foot xerosis in adults: Does cost equate to quality? A randomised, double-blinded clinical trial

Completed

• Conditions: Xerosis of the foot or feet; Skin - Dermatological conditions

• Registration Number: ACTRN12614001076662
• Lead Sponsor: niversity of South Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-10-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Male or female aged >18 yrs

Diagnosis of xerosis indicated by a SRRC score of >2 in dorsal / plantar foot as diagnosed by clinician

Willing and able to provide written consent

Bilateral Xerosis

Exclusion Criteria

Co-existing dermatological disease which may influence xerosis presentation

Co-existing systemic disease which may affect skin physiology

Medications which affect skin integrity / physiology

Allergies to moisturiser ingredients

Concomitant moisturiser, antifungal or steroid use

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
SRRC score, evaluation scaling roughness, redness and cracks.[Baseline & 4 weeks]

Secondary Outcome Measures

Name	Time	Method
VAS score measuring patient - perceived satisfaction of treatment [4 weeks];Patient satisfaction with intervention as scored by VAS[4 weeks]